The GLP-1 receptor is a G-protein-coupled receptor that, when activated in vitro, raises cyclic AMP (cAMP) inside the cell and triggers downstream signaling that researchers measure with cell-based assays. This guide explains the pathway.
What is the GLP-1 receptor?
The GLP-1 receptor is a G-protein-coupled receptor (GPCR) studied widely in incretin research. Reference compounds that engage it are used as tools to probe its signaling.
The cAMP step
When an agonist binds the GLP-1 receptor, the receptor couples to a G-protein that activates the enzyme adenylyl cyclase, raising the level of cyclic AMP (cAMP) in the cell. cAMP is the primary second messenger of this pathway.
Downstream signaling
Raised cAMP activates protein kinase A (PKA) and other cAMP-sensitive effectors, which carry the signal onward. These steps are the readouts that define GLP-1-receptor activity in a cell model.
How it is measured
Cell-based assays quantify cAMP directly, or use reporter systems that light up when the pathway is active. These assays let researchers compare how strongly different reference compounds engage the receptor.
Related research guides
- GLP-1 research overview
- Tirzepatide: dual GIP/GLP-1 agonist
- Cagrilintide & the amylin pathway
- Semaglutide: a researcher's guide
Research-use note
All compounds referenced are supplied for in vitro laboratory research use only.
Related research: RT-GLP3.








